IFT Offers Food Safety Experts on Cyclospora
Institute of Food Technologists (IFT)
The American Society of Clinical Oncology (ASCO) is now recommending that physicians discuss use of the aromatase inhibitor exemestane (Aromasin) to prevent breast cancer in at-risk postmenopausal women. Two breast cancer experts at the University of Maryland Greenebaum Cancer Center are available to comment on the new guideline.